+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cell-based Assay Market by Offerings, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4858028
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cell-based Assay Market grew from USD 20.64 billion in 2023 to USD 22.28 billion in 2024. It is expected to continue growing at a CAGR of 8.11%, reaching USD 35.65 billion by 2030.

Cell-based assays are pivotal in biological research and drug discovery, providing comprehensive insights into cellular functions and interactions. They are defined as analytical experiments conducted in live cells, aimed at understanding cellular mechanisms, drug activity, and cytotoxicity. The necessity of cell-based assays lies in their ability to offer more physiologically relevant data compared to traditional biochemical assays, bridging the gap between in vitro and in vivo studies. Their applications are extensive, encompassing drug screening, receptor-ligand interactions, and genetic function analysis. The end-use scope spans pharmaceuticals, biotechnology companies, academic institutions, and CROs, making them integral to the R&D divisions.

Market growth is influenced by increasing pharmaceutical R&D expenditure, advancements in automation and high-throughput screening technologies, and a rising focus on personalized medicine. Opportunities surface with the growing adoption of 3D cell cultures and organ-on-chip systems, which offer more accurate modeling of human biology. To capitalize on these, companies should invest in developing integrated platforms that marry advanced cell-based technologies with AI and machine learning for enhanced data analytics and predictive modeling.

However, limitations hinder growth, including high costs of advanced assay systems, complexity in data interpretation, and technical challenges associated with reproducing in vivo conditions. Market growth is further challenged by strict regulatory environments and ethical concerns, especially with human-derived cell lines. Innovative research is best directed toward improving assay sensitivity and specificity, developing cost-effective assay kits, and advancing organoid and 3D bioprinting technologies. The market displays a dynamic and competitive nature, characterized by rapid technological advancements and significant collaboration between academic and industrial entities. By focusing on these strategic innovations and mitigating challenges, businesses can leverage substantial growth opportunities within the cell-based assay market.

Understanding Market Dynamics in the Cell-based Assay Market

The Cell-based Assay Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence of chronic diseases and growing drug discovery and development activities
    • Expanding focus on research activities across the world and funding for pharmaceutical research
    • Proliferation of personalized medicine and the demand for customized cell-based assays
  • Market Restraints
    • Complexities in the usage of cell-based assays and lack of skilled personnel
  • Market Opportunities
    • Ongoing innovations to improve the accuracy, efficiency, and performance of cell-based assays
    • Adoption of cell-based assays as a diagnostic tool for detecting certain diseases
  • Market Challenges
    • Performance limitations and technical constraints of cell-based assays

Exploring Porter’s Five Forces for the Cell-based Assay Market

Porter’s Five Forces framework further strengthens the insights of the Cell-based Assay Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cell-based Assay Market

External macro-environmental factors deeply influence the performance of the Cell-based Assay Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cell-based Assay Market

The Cell-based Assay Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cell-based Assay Market

The Cell-based Assay Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cell-based Assay Market

The Cell-based Assay Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell-based Assay Market, highlighting leading vendors and their innovative profiles. These include Abnova Corporation, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Canvax Reagents S.L., Cell Biolabs, Inc., Cell Signaling Technology, Inc., Charles River Laboratories, Inc., Corning Inc., Danaher Corporation, Elabscience Bionovation Inc., Enzo Life Sciences, Inc.,, Eurofins Scientific SE, GE HealthCare Technologies Inc., InSphero AG, Intertek Group plc, InvivoGen, Lonza Group Ltd., Merck KGaA, Molecular Devices, LLC., Perkinelmer, Inc., Promega Corporation, ReadyCell, S.L., Sartorius AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Cell-based Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Offerings
    • Consumables
      • Assay Kits
      • Cell Lines
      • Microplates
      • Probes & Labels
      • Reagents
    • Instruments
    • Services
  • Application
    • Basic Research
    • Drug Discovery
      • Pharmacodynamic Studies
      • Pharmacokinetic Studies
      • Toxicity Studies
  • End-User
    • Academic & Government Institutes
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of chronic diseases and growing drug discovery and development activities
5.1.1.2. Expanding focus on research activities across the world and funding for pharmaceutical research
5.1.1.3. Proliferation of personalized medicine and the demand for customized cell-based assays
5.1.2. Restraints
5.1.2.1. Complexities in the usage of cell-based assays and lack of skilled personnel
5.1.3. Opportunities
5.1.3.1. Ongoing innovations to improve the accuracy, efficiency, and performance of cell-based assays
5.1.3.2. Adoption of cell-based assays as a diagnostic tool for detecting certain diseases
5.1.4. Challenges
5.1.4.1. Performance limitations and technical constraints of cell-based assays
5.2. Market Segmentation Analysis
5.2.1. Offerings: Expanding innovations in consumables of cell-based assays owing to their essential role in the execution of assays
5.2.2. End-User: Extensive utilization of cell-based assays by pharmaceutical and biotechnology companies for drug development process
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cell-based Assay Market, by Offerings
6.1. Introduction
6.2. Consumables
6.2.1. Assay Kits
6.2.2. Cell Lines
6.2.3. Microplates
6.2.4. Probes & Labels
6.2.5. Reagents
6.3. Instruments
6.4. Services
7. Cell-based Assay Market, by Application
7.1. Introduction
7.2. Basic Research
7.3. Drug Discovery
7.3.1. Pharmacodynamic Studies
7.3.2. Pharmacokinetic Studies
7.3.3. Toxicity Studies
8. Cell-based Assay Market, by End-User
8.1. Introduction
8.2. Academic & Government Institutes
8.3. Contract Research Organizations
8.4. Pharmaceutical & Biotechnology Companies
9. Americas Cell-based Assay Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cell-based Assay Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cell-based Assay Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. ARRALYZE launches CellShepherd, a fully autonomous single-cell platform for real-time monitoring of functional assays
12.3.2. InSphero To Revolutionize Oncology Research Through Advanced 3D Cell-Based Assays With ATCC
12.3.3. Beckman Coulter Life Sciences and 10x Genomics Partner
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CELL-BASED ASSAY MARKET RESEARCH PROCESS
FIGURE 2. CELL-BASED ASSAY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CELL-BASED ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. CELL-BASED ASSAY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. CELL-BASED ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CELL-BASED ASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CELL-BASED ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CELL-BASED ASSAY MARKET DYNAMICS
TABLE 7. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PROBES & LABELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACODYNAMIC STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY TOXICITY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. CANADA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 45. CANADA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 46. CANADA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. CANADA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 48. CANADA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 51. MEXICO CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. MEXICO CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 53. MEXICO CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. CHINA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 72. CHINA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 73. CHINA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. CHINA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 75. CHINA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. INDIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 77. INDIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 78. INDIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. INDIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 80. INDIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. JAPAN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 87. JAPAN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 88. JAPAN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. JAPAN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 90. JAPAN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. THAILAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 117. THAILAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 118. THAILAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. THAILAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 120. THAILAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 132. DENMARK CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 133. DENMARK CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 134. DENMARK CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. DENMARK CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 136. DENMARK CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. EGYPT CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 138. EGYPT CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 139. EGYPT CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. EGYPT CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 141. EGYPT CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. FINLAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 143. FINLAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 144. FINLAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. FINLAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 146. FINLAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 149. FRANCE CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. FRANCE CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 151. FRANCE CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 153. GERMANY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 154. GERMANY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. GERMANY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 156. GERMANY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. ITALY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 163. ITALY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 164. ITALY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. ITALY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 166. ITALY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. NORWAY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 178. NORWAY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 179. NORWAY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. NORWAY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 181. NORWAY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. POLAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 183. POLAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 184. POLAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. POLAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 186. POLAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 188. QATAR CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 189. QATAR CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 191. QATAR CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. SPAIN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 208. SPAIN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 209. SPAIN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SPAIN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 211. SPAIN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. TURKEY CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 223. TURKEY CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 224. TURKEY CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. TURKEY CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 226. TURKEY CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. CELL-BASED ASSAY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 238. CELL-BASED ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cell-based Assay Market, which are profiled in this report, include:
  • Abnova Corporation
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Canvax Reagents S.L.
  • Cell Biolabs, Inc.
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories, Inc.
  • Corning Inc.
  • Danaher Corporation
  • Elabscience Bionovation Inc.
  • Enzo Life Sciences, Inc.,
  • Eurofins Scientific SE
  • GE HealthCare Technologies Inc.
  • InSphero AG
  • Intertek Group plc
  • InvivoGen
  • Lonza Group Ltd.
  • Merck KGaA
  • Molecular Devices, LLC.
  • Perkinelmer, Inc.
  • Promega Corporation
  • ReadyCell, S.L.
  • Sartorius AG
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information